Results 71 to 80 of about 877,912 (228)

Successful Percutaneous Septal Alcohol Ablation After Surgical Myectomy

Biomolecules & Biomedicine, 2010
Hypertrophic obstructive cardiomyopathy (HOCM) is a primary, usually familial and genetically fixed myocardial hypertrophy, with dynamic left ventricular outflow tract obstruction.
Mehmed Kulić, Muhamed Spužić, Elnur Tahirović, Šejla Šehović, Vedad Mujačić, Darko Zorman, Vladimir Velebit   +6 more
doaj   +1 more source

Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Journal of Interventional Cardiology, 2005
HOCM is a rare disorder of myocardium that may result in asymmetrical left ventricular septal hypertrophy and dynamic outflow obstruction. This may result in hemodynamic sequel that leads to deterioration of functional class in the majority of patients. Alcohol septal ablation may provide symptomatic relief in the majority of patients who fail medical
Amr E, Abbas, Stacy D, Brewington, Simon R, Dixon, Cindy L, Grines, William W, O'Neill   +4 more
openaire   +2 more sources

Subchronic Exposure to Cannabis‐Based Nanoemulsions Induces Histopathological and Molecular Alterations in the Rat Submandibular Gland

Journal of Applied Toxicology, EarlyView.
ABSTRACT The increasing therapeutic incorporation of cannabis has expanded phytocannabinoid application, yet peripheral adverse effects like xerostomia raise concerns regarding emerging biotechnological formulations. This study evaluated the effects of cannabis‐based lipid nanoemulsions on the rat submandibular gland parenchyma.
Lorrany Avanci Bullo, Gabriel Carvalhal de Aguiar, Daniel Vitor Souza, Barbara dos Anjos Rosário, Flavia de Oliveira, Fernando Augusto Cintra Magalhaes, Nágila Maria Pontes Silva Ricardo, Edilberto Rocha Silveira, Dávila Zampieri, Milena de Barros Viana, Daniel Araki Ribeiro   +10 more
wiley   +1 more source

Mavacamten in Symptomatic Patients Resistant to Previous Advanced Therapy for Obstructive Hypertrophic Cardiomyopathy

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background The clinical benefits of mavacamten in patients with obstructive hypertrophic cardiomyopathy previously treated with advanced therapies are not established.
Daniele Massera, Elizabeth Adlestein, Sumar Frejat, Woon Y. Wu, Maria C. Reuter, Yuhe Xia, Isabel C. Alvarez, Mark V. Sherrid   +7 more
doaj   +1 more source

Two Hearts at Risk

JACC: Case Reports, 2020
Hypertrophic obstructive cardiomyopathy (HOCM) increases the risk for mother and fetus during pregnancy. Alcohol septal ablation (ASA) is an established procedure in nonpregnant patients with HOCM. In this report, we present a case of a 29-year-old woman
Weng-Tein Gi, MD, MSc, Ali Amr, MD, Farbod Sedaghat-Hamedani, MD, Elham Kayvanpour, MD, Isabell Mohr, BSc, Manuela Meder, MD, Omid Shirvani Samani, MD, Herbert Fluhr, MD, Hugo A. Katus, MD, Benjamin Meder, MD   +9 more
doaj   +1 more source

Hypertrophic obstructive cardiomyopathy: alcohol septal ablation [PDF]

, 2017
Alcohol septal ablation (ASA) was introduced in 1994 as an alternative to septal myectomy for patients with hypertrophic obstructive cardiomyopathy and symptoms refractory to medical therapy.
Sigwart, Ulrich, Fifer, Michael A.
core  

Outcomes of the Paramedian Forehead Flap for Nasal Reconstruction: Systematic Review and Meta‐Analysis

The Laryngoscope, EarlyView.
ABSTRACT Objective(s) Paramedian forehead flap (PMFF) reconstruction remains the gold standard for complex nasal defects, yet outcomes have not been comprehensively synthesized. We aimed to define flap survival, complication profiles, and reconstructive patterns through the largest systematic review and meta‐analysis of PMFFs to date.
Renate Ma, Cali Loblundo, Shaun A. Nguyen, Krishna G. Patel, Michelle S. Hwang   +4 more
wiley   +1 more source

Successful alcohol septal ablation for late recurrence of left ventricular outflow tract obstruction after surgical myectomy in hypertrophic obstructive cardiomyopathy [PDF]

, 2008
An 18-year-old male patient, known with familial hypertrophic obstructive cardiomyopathy underwent a septal myectomy 10 years ago for significant left ventricular outflow tract (LVOT) obstruction.
Devos, DanielUZGent0000807592678020014681709712556031600000-0002-5901-490401223882-F0EE-11E1-A9DE-61C894A0A6B4, De Backer, JulieGE35UZGent0019881695908010015849950000-0001-8878-1507FB36A3A4-F0ED-11E1-A9DE-61C894A0A6B4, Tromp, FionaUZGent97231255719224fc7c0a-38e0-11eb-9f20-f565d8bb2ece   +2 more
core   +2 more sources

Micro-coil embolization for transcatheter septal ablation in a hypertrophic obstructive cardiomyopathy patient and an unusual coronary anatomy: a case report

Frontiers in Cardiovascular Medicine
BackgroundTranscatheter septal ablation is a minimally invasive therapeutic method for treating symptomatic obstructive hypertrophic cardiomyopathy (HCM).
Aleksandar Mandic, Gorica Vidovic, Dragana Radoicic, Ivan Ilic, Ivan Ilic   +4 more
doaj   +1 more source

Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: Transcoronary and Endocardial Approach

, 2016
Septal reduction therapy is the gold standard treatment method for symptomatic, hypertrophic obstructive cardiomyopathy. Although surgical myectomy is a well-established and effective technique with decades of experience in its application, use of ...
Yalin, Kıvanç, Ozcan, Kazinn, Aksu, Tolga, Guler, Turner, Golcuk, Sukriye Ebru   +4 more
core   +1 more source